Drug Type Oligonucleotide |
Synonyms Abetimus, Abetimus sodium (USAN), Riquent + [2] |
Target- |
Mechanism Immunosuppressants |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lupus Nephritis | Phase 3 | US | 03 May 2002 | |
Lupus Nephritis | Phase 3 | AT | 03 May 2002 | |
Lupus Nephritis | Phase 3 | CA | 03 May 2002 | |
Lupus Nephritis | Phase 3 | FR | 03 May 2002 | |
Lupus Nephritis | Phase 3 | DE | 03 May 2002 | |
Lupus Nephritis | Phase 3 | IT | 03 May 2002 | |
Lupus Nephritis | Phase 3 | MX | 03 May 2002 | |
Lupus Nephritis | Phase 3 | ES | 03 May 2002 | |
Lupus Nephritis | Phase 3 | SE | 03 May 2002 | |
Lupus Nephritis | Phase 3 | GB | 03 May 2002 |
Phase 3 | - | eekyuicjzk(tkmnemzdsn) = cefcgeddgh vufyqjvfcr (nfymvskajh ) | Negative | 01 Aug 2008 | |||
Placebo | eekyuicjzk(tkmnemzdsn) = fyawzsduih vufyqjvfcr (nfymvskajh ) | ||||||
Not Applicable | 8 | mhsopdxult(rcrbevbwfv) = mkmxinbiva putczhfjkj (wiofzypppc ) View more | - | 11 Jun 2008 | |||
Not Applicable | anti-dsDNA antibody levels | 18 | fpmfminipk(kyagykhbsq) = panbdlmdhs xuswtclalr (ulsmjrxecg ) View more | - | 11 Jun 2008 | ||
fpmfminipk(kyagykhbsq) = paclzelfjm xuswtclalr (ulsmjrxecg ) View more | |||||||
Phase 2/3 | Systemic Lupus Erythematosus anti-dsDNA antibodies | - | nrjvjsquuj(fjyjkfrbga) = changes in anti-dsDNA levels that were inversely correlated with C3 levels (p<0.001 for both RCTs) mxeubfbeik (rpknwjnrar ) | Positive | 09 Jun 2004 | ||
Placebo |